Silicon Valley Capital Partners »

Acelrx Pharmaceuticals shares owned by Silicon Valley Capital Partners

Quarter-by-quarter ownership of Acelrx Pharmaceuticals (TLPH) shares owned by Silicon Valley Capital Partners from 13F filings

Historical chart of Silicon Valley Capital Partners investment in Acelrx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acelrx Pharmaceuticals held by Silicon Valley Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelrx Pharmaceuticals by Silicon Valley Capital Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $141 137 1.03
2023-12-31 $100 137 0.74
2023-09-30 $78 137 0.58
2023-06-30 $152 137 1.11
2023-03-31 $89 137 0.66
2022-12-31 $310 137 2.26

More positions owned by Silicon Valley Capital Partners

Spdr S&p 500 Etf Trust Etf (SPY)
Invesco S&p 500 Garp Etf Etf (SPGP)
Invesco Qqq Trust Series I Etf (QQQ)
Apple Stock (AAPL)
Vanguard Information Technology Etf Etf (VGT)
Microsoft Corp Stock (MSFT)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Nvidia Corporation Stock (NVDA)
Ishares S&p 500 Growth Etf Etf (IVW)
Amazon Stock (AMZN)
Vanguard Growth Etf Etf (VUG)
Vanguard Mega Cap Value Etf Etf (MGV)
Goldman Sachs Activebeta U.s. Large Cap Equity Etf Etf (GSLC)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Starbucks Corp Stock (SBUX)

View all positions for Silicon Valley Capital Partners

Top funds holding Acelrx Pharmaceuticals

Nantahala Capital Management
Rosalind Advisors
Cantor Fitzgerald, L. P.
Tang Capital Management
Vanguard Group
Values First Advisors
Turtle Creek Wealth Advisors
Virtu Financial
Citadel Advisors
Millennium Management
Jane Street
UBS Group
Advisor Group Holdings
Wells Fargo & Company
Advisory Services Network

View all funds holding Acelrx Pharmaceuticals